You are subscribed to one or more CDC code sets email subscription services. Subscription links are available on each of the pages below.
Code Set Update Publication Date: January 29, 2021
The individual file names included in this distribution contain the publication date (20210129)
Release Notes: This release includes both the Vaccine Code Set Updates and the Vaccine Information Statement (VIS) codes and maps.
General Note regarding this release: Codes included with “Last Update” dates January 13 to February 1, 2021 to reflect the changes and additions in this release. It includes the following code set updates:
A. Vaccine Code Updates
1) COVID-19 Potential Pre-EUA Vaccine Code Additions and Updates:
COVID-19 Vaccine Codes and Crosswalks for one additional vaccine have been included in this release in anticipation of potential vaccine availability under Emergency Use Authorization (EUA). These codes will become effective if and only when the Food and Drug Administration (FDA) authorizes use of COVID-19 vaccine(s) under an EUA and ACIP votes to recommend the vaccines. The advance release of these codes is intended to help end user organizations prepare their systems ahead of vaccine distribution.
The CVX codes are listed as active. If EUA authorization and ACIP recommendations are not received, the codes will be inactivated. The NDC codes are currently listed by the FDA as “unauthorized” and these NDC codes will be activated upon receipt of an EUA authorization.
A separate downloadable table of just COVID-19 codes is also available on the CDC website vaccine code sets page and has been updated to reflect new NDCs for the COVID-19 vaccine and the new CPT codes.
https://www.cdc.gov/vaccines/programs/iis/COVID-19-related-codes.html
The AMA COVID-19 CPT codes for these potential EUA vaccines are also available and included in the CPT to CVX crosswalk downloadable file. American Medical Association (AMA) COVID-19 CPT® vaccine product and administration codes are available on the AMA web site:
https://www.ama-assn.org/practice-management/cpt/covid-19-cpt-vaccine-and-immunization-codes
The codes and crosswalks for candidate COVID-19 vaccines will continue to be released in phases as the late-stage clinical trials for candidate vaccines progress.
One potential new EUA candidate vaccine is included in this release as follows:
Product Name: Janssen (J&J) COVID-19 Vaccine: The CVX Code, CPT Code, and NDC Codes and Product are new in this release
- CVX Code = 212, CVX Short Description “COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL”
- MVX Code = JSN, “Janssen”
- NDC Labeler = Janssen Products, LP
- NDC Unit of Sale: NDC10 = 59676-580-15, NDC11 = 59676-0580-15; CARTON, 10 MULTI-DOSE VIALS
- NDC Unit of Use: NDC10 = 59676-580-05, NDC11 = 59676-0580-05; VIAL, MULTI-DOSE, 2.5mL
- CPT to CVX Map – CPT Code = 91303 represents specific AMA CPT vaccine product code associated to this vaccine CVX code
- Product/Tradename = “Janssen COVID-19 Vaccine”
2) NDC Additions and Updates – Not COVID-19 Related:
The following NDC pairs were previously retired by FDA with no replacement NDCs – Status changed to active in this release
